guidelines:
  1: Crusade_Score_Assessment.v1
test_cases:
- id: very_low_risk(score<=20)
  input:
    1:
      gt0006|Total score: 15
  expected_output:
    1:
      gt0019|Risk level: 0|local::at0009|Very low risk (3.1%)|
      gt0020|Recommendation: 0|local::at0004|Initiation of anti-thrombotic and invasive therapies is reasonable given a relatively low risk of major bleeding.|

- id: low_risk(21<=score<=30)
  input:
    1:
      gt0006|Total score: 25
  expected_output:
    1:
      gt0019|Risk level: 1|local::at0010|Low risk (5.5%)|
      gt0020|Recommendation: 1|local::at0005|Initiation of anti-thrombotic and invasive therapies should be considered|

- id: moderate_risk(31<=score<=40)
  input:
    1:
      gt0006|Total score: 35
  expected_output:
    1:
      gt0019|Risk level: 2|local::at0011|Moderate risk (8.5%) |
      gt0020|Recommendation: 2|local::at0006|Initiation of anti-thrombotic and invasive therapies should be considered.|

- id: high_risk(41<=score<=50)
  input:
    1:
      gt0006|Total score: 45
  expected_output:
    1:
      gt0019|Risk level: 3|local::at0012|High risk (11.9%)|
      gt0020|Recommendation: 3|local::at0007|Judicious use of anti-thrombotic and invasive therapies is prudent in this high risk of bleeding group.|

- id: very_high_risk(score>50)
  input:
    1:
      gt0006|Total score: 60
  expected_output:
    1:
      gt0019|Risk level: 4|local::at0014|Very high risk (19.5%)|
      gt0020|Recommendation: 4|local::at0008|Judicious use of anti-thrombotic and invasive therapies is prudent in this very high risk of bleeding group.|
